RYZODEG FLEXITOUCH 3ML

About

Ryzodeg FlexTouch 3ml is a co-formulation of insulin degludec (a long-acting basal insulin) and insulin aspart (a rapid-acting mealtime insulin). This innovative combination provides both basal insulin coverage for sustained glucose control and bolus insulin for post-meal glucose excursions, all in a single injection. It is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above. Insulin degludec forms soluble multi-hexamers upon subcutaneous injection, creating a subcutaneous depot from which insulin is slowly and continuously absorbed into the circulation, providing a flat and stable glucose-lowering effect for over 42 hours. Insulin aspart, on the other hand, acts rapidly to cover mealtime glucose spikes.

The dual action of Ryzodeg offers flexibility in dosing, typically administered once or twice daily with the main meal(s). This simplifies insulin regimens for patients, potentially improving adherence and overall glycemic control. Patients should be thoroughly educated on proper injection technique, dose titration, and the importance of blood glucose monitoring. As with all insulin products, careful management is required to prevent hypoglycemia, the most common side effect. Regular follow-up with a healthcare provider is essential to adjust doses and monitor for any adverse effects, ensuring optimal and safe diabetes management.

Uses

• Treatment of Type 1 Diabetes Mellitus
• Management of Type 2 Diabetes Mellitus
• Provides both basal and mealtime insulin coverage
• Aids in achieving target blood glucose levels

Directions For Use

Inject subcutaneously once or twice daily with the main meal(s) as prescribed. Rotate injection sites to prevent lipodystrophy.

Benefits

• Combines basal and rapid-acting insulin in one injection
• Offers flexible dosing schedule (once or twice daily)
• Provides sustained glucose control for over 42 hours
• Effectively manages post-meal glucose spikes
• Simplifies insulin regimen for patients
• Reduces the number of daily injections

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (pain, redness, swelling)
• Lipodystrophy (fat accumulation or atrophy)
• Weight gain
• Allergic reactions
• Peripheral edema
• Pruritus
• Rash
• Urticaria
• Blurred vision (temporary)
• Diabetic retinopathy worsening (temporary)
• Hypokalemia (low potassium)

Safety Measures

• Alcohol - Alcohol can lower blood sugar and increase the risk of hypoglycemia. Use with caution and monitor glucose levels.
• Pregnancy - Consult a doctor. Insulin requirements may change during pregnancy. Close monitoring is essential.
• Breastfeeding - Generally considered safe, but consult a healthcare provider. Insulin does not pass into breast milk in significant amounts.
• Liver - Use with caution in hepatic impairment; insulin requirements may be altered. Monitor glucose levels closely.
• Kidney - Use with caution in renal impairment; insulin requirements may be altered. Monitor glucose levels closely.
• Lung - No specific contraindications for lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.